or
forgot password
  • cancer clinical trials in bethlehem, PA

  • Vaccine Therapy for Patients With Stage IV Melanoma
    St. Lukes Hospital Cancer Center
    Bethlehem, Pennsylvania 18015
    Malignant Melanoma
    Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    St. Luke's Hospital Cancer Center
    Bethlehem, Pennsylvania 18015
    Breast Cancer
    Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer
    St. Luke's Network - Bethlehem
    Bethlehem, Pennsylvania 18015
    Colorectal Cancer
    Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
    St. Luke's Hospital Cancer Center
    Bethlehem, Pennsylvania 18015
    Breast Cancer
    Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
    St. Luke's Hospital Regional Cancer Center
    Bethlehem, Pennsylvania 18015
    Lung Cancer
    Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord
    St. Luke's Hospital Cancer Center
    Bethlehem, Pennsylvania 18015
    Head and Neck Cancer
    Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
    St. Luke's Hospital Regional Cancer Center
    Bethlehem, Pennsylvania 18015
    Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Oral Complications, Radiation Toxicity
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    St. Luke's Hospital Cancer Center
    Bethlehem, Pennsylvania 18015
    Breast Cancer
    Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
    St. Luke's Hospital Regional Cancer Center
    Bethlehem, Pennsylvania 18015
    Bladder Cancer
    Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
    St. Luke's Hospital Cancer Center
    Bethlehem, Pennsylvania 18015
    Prostate Cancer
    Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    St. Luke's Hospital Cancer Center
    Bethlehem, Pennsylvania 18015
    Prostate Cancer
    Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme
    St. Luke's Hospital Cancer Center
    Bethlehem, Pennsylvania 18015
    Brain and Central Nervous System Tumors
    Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
    St. Luke's Hospital Regional Cancer Center
    Bethlehem, Pennsylvania 18015
    Cognitive/Functional Effects, Metastatic Cancer, Radiation Toxicity
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    St. Luke's Cancer Network at St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Lung Cancer
    Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
    St. Luke's Hospital Cancer Center
    Bethlehem, Pennsylvania 18015
    Head and Neck Cancer
    Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
    St. Luke's Hospital and Health Network
    Bethlehem, Pennsylvania 18015
    Alzheimer Disease
    Vaccine Therapy for Patients With Stage III Melanoma
    St. Lukes Hospital Cancer Center
    Bethlehem, Pennsylvania 18015
    Malignant Melanoma
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    St. Luke's Cancer Network at St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Esophageal Cancer, Gastric Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    St. Luke's Cancer Network at St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Endometrial Cancer
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    St. Luke's Hospital Cancer Center
    Bethlehem, Pennsylvania 18015
    Kidney Cancer
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    St. Luke's Cancer Network at St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Breast Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    St. Luke's Cancer Network at St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Study of Late-Occurring Complications in Childhood Cancer Survivors
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Cancer Survivor, Cardiovascular Complications, Hematopoietic/Lymphoid Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
    Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Brain Tumor, Central Nervous System Tumor
    Ixabepilone in Treating Patients With Metastatic Prostate Cancer
    St. Luke's Cancer Network at St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Prostate Cancer
    Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    St. Luke's Hospital Cancer Center
    Bethlehem, Pennsylvania 18015
    Brain and Central Nervous System Tumors
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    St. Luke's Cancer Network at St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Breast Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Leukemia
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    S-1 as Second-Line Therapy in Treating Patients With Unresectable or Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer
    Vita Hematology Oncology at St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Lung Cancer
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    St. Luke's Cancer Network at St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Colorectal Cancer
    Trial of Myocet in Metastatic Breast Cancer
    Vita Hematology Oncology
    Bethlehem, Pennsylvania 18015
    Breast Cancer
    Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
    St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Melanoma
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole
    St. Luke's Cancer Network at St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Breast Cancer
    Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma
    St. Luke'S Hospital & Health Network
    Bethlehem, Pennsylvania 18015
    Melanoma
    Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma
    St. Luke's Cancer Network at St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Intraocular Melanoma, Melanoma (Skin), Metastatic Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Kidney Cancer
    Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Neurofibrosarcoma, Adult Synovial Sarcoma, Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Malignant Mesenchymoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans, Localized Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Childhood Malignant Mesenchymoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Leukemia, Myelodysplastic Syndromes
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Stage III Wilms Tumor, Stage IV Wilms Tumor
    Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    St. Luke's Cancer Network at St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Esophageal Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    St. Luke's Cancer Network at St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Breast Cancer
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Untreated Childhood Medulloblastoma, Untreated Childhood Pineoblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
    St. Luke's Cancer Network at St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Breast Cancer
    Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
    St. Luke's Cancer Network at St. Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Anal Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Endometrial Cancer
    Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Neuroblastoma